Modern strategies for optimizing the management of patients with myocardial infarction and atrial fibrillation

Authors

DOI:

https://doi.org/10.14739/mmt.2025.1.303513

Keywords:

atrial fibrillation, myocardial infarction, cardiac rehabilitation

Abstract

The aim of the study – to analyze and summarize information from the scientific literature on modern approaches to the management of patients with acute myocardial infarction and atrial fibrillation, as well as to identify promising directions for research in this category of patients.

Materials and methods. We searched in the scientometric systems of Google Scholar, PubMed, Cochrane Database, conducted a synthesis, comparison, generalization and system-structural analysis of modern scientific literary sources.

Results. The analysis of information in the modern scientific literature demonstrates that patients with combined cardiovascular pathology, in particular acute myocardial infarction with atrial fibrillation (AF), have a higher risk of mortality, a higher frequency of repeated cardiovascular events and a severe course of the underlying disease, which complicates the management of this category of patients. Despite all efforts to improve the AF management system, in the last decade the incidence of AF continues to grow, the age of patients is decreasing, the number of patients with two or more cardiovascular disease risk factors rises, which increases the frequency of AF-related complications. The use of mobile applications to solve clinical tasks in patients with AF has proven its effectiveness and is actively used in practice. Among the components of myocardial infarction and AF management, revascularization, drug treatment and rehabilitation have the highest level of evidence and significantly reduce mortality. It should be noted that existing rehabilitation protocols do not include restorative treatment programs for patients with combined cardiovascular pathology. Different rehabilitation strategies for myocardial infarction and atrial fibrillation create difficulties in managing these pathologies in combination.

Conclusions. Optimizing the management of patients with myocardial infarction and atrial fibrillation through the development of rehabilitation programs will help unify the approach to this category of patients. The use of telemedicine elements for rehabilitation treatment will expand the limits of patients’ access to cardiac rehabilitation resources, increase their adherence and improve treatment effectiveness.

Author Biographies

L. V. Levytska, Ivan Horbachevsky Ternopil National Medical University of the Ministry of Health of Ukraine

MD, PhD, DSc, Professor of the Department of Emergency Medical Care

U. A. Dmyterko, Kyiv St. Michael Clinical Hospital

MD, PhD student, Cardiologist, Kyiv St. Michael Clinical Hospital

References

  1. Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716-99. doi: https://doi.org/10.1093/eurheartj/ehz859
  2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 2020;76:2982-3021. doi: https://doi.org/10.1016/j.jacc.2023.11.007
  3. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217-21. doi: https://doi.org/10.1177/1747493019897870. Erratum in: Int J Stroke. 2020;15(9):NP11-NP12. doi: https://doi.org/10.1177/1747493020905964
  4. Cottin Y, Maalem Ben Messaoud B, Monin A, Guilleminot P, Bisson A, Eicher J-C, et al. Temporal relationship between atrial fibrillation and heart failure development analysis from a nationwide database. J Clin Med. 2021;10:5101. doi: https://doi.org/10.3390/jcm10215101
  5. Sadat B, Al Taii H, Sabayon M, Narayanan CA. Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations. Curr Cardiol Rep. 2024;26(5):313-23. doi: https://doi.org/10.1007/s11886-024-02040-7
  6. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-826. doi: https://doi.org/10.1093/eurheartj/ehad191. Erratum in: Eur Heart J. 2024;45(13):1145. doi: https://doi.org/10.1093/eurheartj/ehad870
  7. Soliman EZ, Rahman AF, Zhang ZM, Rodriguez CJ, Chang TI, Bates JT, et al. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation. Hypertension. 2020;75(6):1491-6. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.14766
  8. Van den Dries CJ, van Doorn S, Rutten FH, Oudega R, van de Leur S, Elvan A, et al. Integrated management of atrial fibrillation in primary care: results of the ALL-IN clus ter randomized trial. Eur Heart J. 2020;41:2836-44. doi: https://doi.org/10.1093/eurheartj/ehaa055
  9. Zakeri R, Morgan AD, Sundaram V, Bloom C, Cleland JGF, Quint JK. Under-recognition of heart failure in patients with atrial fibrillation and the impact of gender: a UK population-based cohort study. BMC Med. 2021;19(1):179. doi: https://doi.org/10.1186/s12916-021-02048-8
  10. Brady PF, Chua W, Nehaj F, Connolly DL, Khashaba A, Purmah YJV, et al. Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death. J Am Heart Assoc. 2022;11(4):e022833. doi: https://doi.org/10.1161/JAHA.121.022833
  11. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1261-74. doi: https://doi.org/10.1001/jama.2019.0693
  12. Bunting KV, Van Gelder IC, Kotecha D. STEEER-AF: a cluster-randomized education trial from the ESC. Eur Heart J. 2020;41:1952-4. doi: https://doi.org/10.1093/eurheartj/ehaa421
  13. Belkouche A, Yao H, Putot A, Chagué F, Rochette L, Danchin N, et al. The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review. J Clin Med. 2021;10(2):198. doi: https://doi.org/10.3390/jcm10020198
  14. Akao M, Shimizu W, Atarashi H, Ikeda T, Inoue H, Okumura K, et al. Oral anticoagulant use in elderly Japanese patients with non-valvular atrial fibrillation: Subanalysis of the ANAFIE Registry. Circ Rep. 2020;2(10):552-9. doi: https://doi.org/10.1253/circrep.cr-20-0082
  15. Elbadawi A, Sedhom R, Gad M, Hamed M, Elwagdy A, Barakat AF, et al. Screening for atrial fibrillation in the elderly: a network meta-analysis of randomized trials. Eur J Intern Med. 2022;105:38-45. doi: https://doi.org/10.1016/j.ejim.2022.07.015
  16. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. doi: https://doi.org/10.1093/eurheartj/ehaa612
  17. Harskamp RE, Fanaroff AC, Lopes RD, Wojdyla DM, Goodman SG, Thomas LE, et al. Antithrombotic therapy in patients with atrial fibrillation after acute coronary syn dromes or percutaneous intervention. J Am Coll Cardiol. 2022;79(5):417-27. doi: https://doi.org/10.1016/j.jacc.2021.11.035
  18. Alexander JH, Wojdyla D, Vora AN, Thomas L, Granger CB, Goodman SG, et al. Risk/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS. Circulation 2020;141(20):1618-27. doi: https://doi.org/10.1161/circulationaha.120.046534
  19. Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, et al. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry. Clin Res Cardiol Off J Ger Card Soc. 2022;111(1):70-84. doi: https://doi.org/10.1007/s00392-021-01914-y
  20. Bodin A, Bisson A, Gaborit C, Herbert J, Clementy N, Babuty D, et al. Ischemic stroke in patients with sinus node disease, atrial fibrillation, and other cardiac conditions. Stroke. 2020;51(6):1674-81. doi: https://doi.org/10.1161/strokeaha.120.029048
  21. Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, et al. Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. JAMA Cardiol. 2020;5(5):582-589. doi: https://doi.org/10.1001/jamacardio.2019.6175
  22. Ko D, Benson MD, Ngo D, Yang Q, Larson MG, Wang TJ, et al. Proteomics profiling and risk of new-onset atrial fibrillation: Framingham heart study. J Am Heart Assoc. 2019;8(6):e010976. doi: https://doi.org/10.1161/jaha.118.010976
  23. Kaikita K, Yasuda S, Akao M, Ako J, Matoba T, Nakamura M, et al. Bleeding and subsequent cardiovascular events and death in atrial fibrillation with stable coronary artery disease: Insights from the AFIRE Trial. Circ Cardiovasc Interv. 2021;14(11):e010476. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.120.010476
  24. Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, et al. Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction. J Am Heart Assoc. 2021;10(18):e021417. doi: https://doi.org/10.1161/JAHA.121.021417
  25. Mokgokong R, Schnabel R, Witt H, Miller R, Lee TC. Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries. PLoS One. 2022;17(7):e0269867. doi: https://doi.org/10.1371/journal.pone.0269867
  26. Pinho-Gomes AC, Azevedo L, Copland E, Canoy D, Nazarzadeh M, Ramakrishnan R, et al. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis. PLoS Med. 2021;18(6):e1003599. doi: https://doi.org/10.1371/journal.pmed.1003599
  27. Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GY. Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort. Mayo Clin Proc. 2019;94(7):1261-7. doi: https://doi.org/10.1016/j.mayocp.2018.10.022
  28. Yoon M, Yang PS, Jang E, Yu HT, Kim TH , Uhm JS, et al. Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study. Thromb Haemost. 2019;119(10):1695-703. doi: https://doi.org/10.1055/s-0039-1693516
  29. Ugowe FE, Jackson LR 2nd. Atrial fibrillation and mortality risk: seeing the big picture. Eur Heart J Qual Care Clin Outcomes. 2019;5(1):6-7. doi: https://doi.org/10.1093/ehjqcco/qcy050
  30. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-337. doi: https://doi.org/10.1093/eurheartj/ehab484. Erratum in: Eur Heart J. 2022;43(42):4468. doi: https://doi.org/10.1093/eurheartj/ehac458
  31. Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015;128(5):509-18.e2. doi: https://doi.org/10.1016/j.amjmed.2014.11.026
  32. Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452-469. doi: https://doi.org/10.1093/eurheartj/ehac747
  33. Scherrenberg M, Falter M, Dendale P. Cost-effectiveness of cardiac telerehabilitation in coronary artery disease and heart failure patients: systematic review of randomized controlled trials. Eur Heart J Digit Health. 2020;1(1):20-9. doi: https://doi.org/10.1093/ehjdh/ztaa005
  34. Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28(5):460-95. doi: https://doi.org/10.1177/2047487320913379
  35. Dibben G, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler A-D, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021;11(11):CD001800. doi: https://doi.org/10.1002/14651858.CD001800.pub4

Downloads

Additional Files

Published

2025-03-25

How to Cite

Levytska, L. V., & Dmyterko, U. A. (2025). Modern strategies for optimizing the management of patients with myocardial infarction and atrial fibrillation. Modern Medical Technology, 17(1), 46–50. https://doi.org/10.14739/mmt.2025.1.303513

Issue

Vol. 17 No. 1 (2025)

Section

Reviews of literature

License

Copyright (c) 2025 Levytska L. V., Dmyterko U. A.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The work is provided under the terms of the Public Offer and of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows an unlimited number of persons to reproduce and share the Licensed Material in all media and formats. Any use of the Licensed Material shall contain an identification of its Creator(s) and must be for non-commercial purposes only.